Role of IL-11 in vascular function of pulmonary fibrosis patients

  1. Ines Roger 2
  2. Cristina Estornut 1
  3. Beatriz Ballester 1
  4. Javier Milara 3
  5. Julio Cortijo 1
  1. 1 Universitat de València
    info

    Universitat de València

    Valencia, España

    ROR https://ror.org/043nxc105

  2. 2 CIBERES, Valencia, Spain
  3. 3 Hospital General Universitario de Valencia
    info

    Hospital General Universitario de Valencia

    Valencia, España

    ROR https://ror.org/03sz8rb35

Proceedings:
European Respiratory Journal

Publisher: European Respiratory Society

ISSN: 0903-1936 1399-3003

Year of publication: 2019

Volume: 54

Issue: suppl 63

Type: Conference paper

DOI: 10.1183/13993003.CONGRESS-2019.PA1424 GOOGLE SCHOLAR lock_openOpen access editor

Abstract

Pulmonary hypertension (PH) in idiopathic pulmonary fibrosis (IPF) portends a poor prognosis. Currently, no therapy can improve survival of patients diagnosed with this disease. IL-11 molecular pathway is over-expressed in proliferative disorders, however, its role in PH- associated IPF is unknown. The aim of this study was to evaluated the expression of IL-11 in IPF patients with or without PH. Also we hypothesized that the stimulation of pulmonary artery smooth muscle cells (PASMCs) and human pulmonary artery microvascular endothelial cells (HMVEC-L) with IL-11 induced the transformation into invasive myofibroblast. Human pulmonary artery rings, parenchyma tissue, broncho-alveolar lavage (BAL) and serum were obtained from control subjects (n=32), IPF (n=26) and IPF with PH patients (n=22) to study the expression and predominant distribution of IL-11 and IL-11Ra. The effect of recombinant human IL-11 on pulmonary artery remodeling was evaluated in isolated PASMCs and HMVEC-L. IL-11 and IL-11Ra were over-expressed in pulmonary arteries, parenchyma, serum and BAL of IPF patients with PH and in a lesser extend in IPF patients compared with control subjects. The inmunostaining and inmunofluorescence revealed a predominant distribution of IL11 and IL-11Rα in remodeled pulmonary arteries of IPF patients and in a greater extend in IPF with PH patients and no expression in control subject. IL-11 induced morphological changes in isolated PASMCs and HMVEC-L characterized by myofibroblast phenotype. IL-11 and IL-11Rα are over expressed in pulmonary arteries of IPF + PH patients contributing to pulmonary artery remodeling. Pharmacologic modulation of this route may be a promising target for the treatment of this disease.Footnotes Cite this article as: European Respiratory Journal 2019; 54: Suppl. 63, PA1424.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at [www.ers-education.org][1] (ERS member access only). [1]: http://www.ers-education.org